Chuka J. Anude, Ph.D.
Affiliations: | 2011 | Johns Hopkins University, Baltimore, MD |
Area:
Epidemiology, Public Health, Medicine and SurgeryGoogle:
"Chuka Anude"Cross-listing: Epi Tree
Parents
Sign in to add mentor| Andrea Ruff | grad student | 2011 | Johns Hopkins | |
| (The HACART study Predictors and prediction modeling of loss to follow-up, immuno-virologic outcomes and sub-optimal drug adherence among adults on antiretroviral therapy in Nigeria.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Janes HE, Cohen KW, Frahm N, et al. (2017) Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial. The Journal of Infectious Diseases |
| Dawson L, Garner S, Anude C, et al. (2015) Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial. Clinical Trials (London, England). 12: 394-402 |
| Garner SA, Anude CJ, Adams E, et al. (2014) Ethical considerations in HIV prevention and vaccine research in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 77-83 |
| Hammer SM, Sobieszczyk ME, Janes H, et al. (2013) Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. The New England Journal of Medicine. 369: 2083-92 |
| Anude CJ, Eze E, Onyegbutulem HC, et al. (2013) Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria Bmc Infectious Diseases. 13 |
| Anude CJ, Eze E, Onyegbutulem HC, et al. (2012) AF6 The HACART Study: Predictors of Immuno-Virologic Outcomes and Immuno-Virologic Discordance Among Adults on HIV Antiretroviral Therapy in Nigeria Journal of Acquired Immune Deficiency Syndromes. 59: 30 |